Among the downstream genes, LOXL2, is of particular interest for the further study, considering it was proved to be a biomarker in CRC (Fig.1a, Fig.S6a-b), as well as it was in the same cluster of protein-protein interaction (PPI) network as ETV4 (Fig.1b). This evidence concerns the gene LOXL2 and colorectal carcinoma.